Tryptase, TLR4, and anti-NR2A antibodies were measured in serum, cerebrospinal fluid, and subjects and other markers to assess their relevance to disease activity, aiming to find new therapeutic targets,Timely intervention to improve the prognosis of SLE and improve the quality of life of patients with SLE.
This study is a prospective cohort study: it is proposed to be divided into 3 groups, namely healthy control group and SLE group, NPSLE epilepsy group; Fifteen cases were included in each group, with the consent of the subjects and signed to know Consent form, record all subjects' clinical and laboratory test data, and test subjects' blood. Markers such as cerebrospinal fluid tryptase, TLR4 and anti-NR2A antibodies, follow-up 2 year, the patient's disease activity is evaluated every year, the change of indicators is dynamically observed, and statistical points are made divide.
Study Type
OBSERVATIONAL
Enrollment
45
Qin Huang
Guangzhou, Guangdong, China
RECRUITINGChanges in disease activity index
SLEDAI
Time frame: Baseline, months 3, 6, 9, 12, 15, 18, 21, and 24
Numerical changes in markers such as tryptase, TLR4, and anti-NR2A antibodies in blood and cerebrospinal fluid
Time frame: Baseline, months 3, 6, 9, 12, 15, 18, 21, and 24
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.